COMMUNIQUÉS West-GlobeNewswire

E-Star BioTech Set to Initiate Phase 2 Clinical Trial of MANP in Resistant Hypertension With Support of Latest Investment

08/10/2024 - 15:00

NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, metabolic, and kidney diseases, today announced [...]

Growth.Health Announces Launch of Powerful Data & Analytics Platform

08/10/2024 - 15:02

G1 Platform Proves Unsurpassed Customer and Prospect Insights Via Privacy Preserving Records Linkage and Marketing Operationalization ATLANTA, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Growth.Health today announced the launch [...]

Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping

08/10/2024 - 16:00

The unique assay enables laboratories to provide clinicians with more informed treatment decisions for their patients NEW HAVEN, Conn., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, [...]

Sevaro Partners with Rosman Search to Elevate Neurology Services in Hospitals Nationwide

08/10/2024 - 16:00

EAST BRUNSWICK, N.J., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Sevaro, a leading provider of virtual neurology technology platforms and teleneurology services , proudly announces a strategic partnership with Rosman Search. [...]

Curia dévoile une marque plus moderne à l'occasion du salon de la CPHI Worldwide qui se tient à Milan

08/10/2024 - 16:02

La marque sophistiquée met en valeur les principales capacités de Curia et son approche personnalisée en matière de petites molécules, d’IPA génériques et de produits biologiques ALBANY, New York, 08 oct. 2024 (GLOBE [...]

ARC Fertility and Sapyen Announce Strategic Partnership to Revolutionize Male Fertility Testing, Expanding Reproductive Health Benefits for Employers and Workforces

08/10/2024 - 16:11

CUPERTINO, Calif. and MELBOURNE, Australia, Oct. 08, 2024 (GLOBE NEWSWIRE) -- ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for employers and their [...]

From Ideation to Commercialization: Nutrify Today’s NutrifyGenie Exceeds AI Expectations

08/10/2024 - 16:26

BANGALORE, India, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Nutrify Today ’s AI platform, NutrifyGenie , is redefining the nutraceutical industry by taking product concepts from idea to full-scale commercialization. By [...]

EchoNous Partners with Mendaera to Revolutionize Image-Guided Intervention

08/10/2024 - 17:36

REDMOND, Wash. and SAN MATEO, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- EchoNous, a pioneer in portable ultrasound technology, has announced a commercial partnership with Mendaera, a Silicon Valley-based healthcare [...]

Scilex Holding Company Announces Closing of a $50 Million Registered Convertible Financing

08/10/2024 - 17:50

PALO ALTO, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]

Qinotto and Lilly Enter Research Collaboration and License Agreement

08/10/2024 - 18:00

Combination of Qinotto’s novel blood brain barrier platform and Lilly's therapeutic expertise could boost the delivery of large molecule therapeutics to the brain SAN CARLOS, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- [...]

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Quarter Ended September 30, 2024

08/10/2024 - 19:58

ZTlido net sales for the quarter ended September 30, 2024 were in the range of $11.0 million to $13.0 million, compared to $10.1 million for the same period last year, representing growth in the range of approximately 9 [...]

Key-Whitman Eye Center Selects Nextech

08/10/2024 - 20:30

Ophthalmology Platform to Automate Clinical Operations TAMPA, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Nextech, market leader of comprehensive technology solutions for specialty physician practices, today announced Key- [...]

Tevogen Bio Highlights Promising Trial Data as CEO Leads Patient Advocacy at Capitol Hill, Pledging to Leverage Multi-Billion Dollar Company Assets to Combat Long COVID and Spearhead a New Wave of Medical Innovation

08/10/2024 - 20:40

The primary study endpoints were related to safety. No dose-limiting toxicities or significant adverse events related to TVGN 489, including Cytokine Release Syndrome, were observed in any patient at any dose level. [...]

Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show

08/10/2024 - 21:15

KANSAS CITY, Kan., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Shane J. Schaffer, Chairman and CEO of Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug [...]

Disclosure of notification received from AOC Pharma S.à r.l.

08/10/2024 - 22:00

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 8 October 2024 – 9:00 PM CET Disclosure of notification received from AOC Pharma S.à r.l. Pursuant to the Belgian law of 2 May 2007 regarding the [...]

Solera Health Unveils New Brand Identity Reflecting the Company's Leadership at the Intersection of Healthcare and Technology

08/10/2024 - 22:00

Rebrand Underscores the Company's Mission to Redefine and Streamline Digital Healthcare Delivery PHOENIX, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Solera Health , a unique technology platform for connecting people seamlessly [...]

MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue

08/10/2024 - 22:01

Story Featured Patients Treated with MIMEDX Products MARIETTA, Ga., Oct. 08, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today highlighted the publication of a feature article [...]

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

08/10/2024 - 22:01

BOSTON, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases [...]

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

08/10/2024 - 22:01

SAN DIEGO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]